Clinical Trial Update: Enoxaparin Versus Unfractionated Heparin in PCI [Phase 4]

View source ↗

Summary

Phase 4 trial comparing enoxaparin with unfractionated heparin in percutaneous coronary intervention has completed. The study concerns patients with Coronary Ar…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Coronary Artery Disease

Drugs mentioned

• Lovenox (enoxaparin) (enoxaparin)
• Unfractionated Heparin (unfractionated heparin)

Snippet

Sponsor: Triemli Hospital | Conditions: Coronary Artery Disease | Phase 4 | Status: COMPLETED